On 25th November 2016, Indo Count Industries declared its results for the Q2FY17. The September quarter has seen the rise in the net profit to Rs. 627.2 million as compared to Rs. 516.4 million in the corresponding quarter last financial year. The September quarter of the ongoing financial year also witnessed the decline in the net sales to Rs. 5.53 billion from Rs. 5.65 billion in the year ago quarter.
For the first half of the ongoing financial year, Indo Count’s total Income went up by 3.3 per cent annually, EBIDTA increased 9.8 per cent and EBITDA margin grew by 130 basis points. In the H1FY17, the company’s net profit grew by 18.9 per cent.
(Rs in Crs) | H1 FY17* | H1 FY16* | Growth % |
Total Income | 1068.98 | 1034.40 | 3.3% |
EBIDTA | 226.66 | 206.38 | 9.8% |
EBITDA% | 21.2% | 19.9% | +130 bps |
PBDT | 205.25 | 176.18 | 16.5% |
PAT | 122.73 | 103.23 | 18.9% |
PAT% | 11.5% | 10.0% | +150 bps |
EPS(diluted) (Rs.) | 31.16 | 26.29 | 18.5% |
Cash Profit | 170.32 | 132.63 | 28.4% |
Long Term Debt: Equity | 0.03 | 0.15 | - 80.0% |
At 12:50 PM, Indo Count share price was trading at Rs. 156.30, up by 9.57 per cent.
Also, ICRA and CARE upgraded Indo Count‘s rating to “ICRA AA- with Stable Outlook / CARE AA- (Double A minus) for Long Term Bank Facilities Fund based term loans from ICRA A / CARE A signifying high degree of safety regarding timely servicing of financial obligations. Such facilities carry very low credit risk. ICRA A1+ / CARE A1+ (A One Plus) from ICRA A1 / CARE A1 for Short Term Bank Facilities (Fund and Non Fund based) signifying very strong degree of safety regarding timely payment of financial obligations. Such facilities carry lowest credit risk.
Indo Count is analyzed by Dynamic Levels as the top 500 performing stocks for this quarter. For the details on the stock, visit Indo Count share price history page of Dynamic Levels website.
I just came across this site and found this informative blog about dentistry. Thanks for sharing. Realy, it's a great blog. I think Mindspace REIT IPO may useful for you. Check once and get more facts.
ReplyDeleteFaering Capital ACSYS Investments
Bafna Pharmaceuticals Ltd. Live Share Price
Bacil Pharma Ltd Live Share Price